AI-Integrated Phenobarbital Sodium Stabilization System

A novel system integrating AI, IoT, blockchain, and advanced materials to enhance the stability and quality of phenobarbital sodium for injection, ensuring real-time monitoring and optimization throughout the supply chain and administration process.

The original patent disclosed a lyophilized pharmaceutical composition of phenobarbital or salts thereof with improved stability. However, the patent did not address the need for real-time monitoring, optimization, and verification of the composition throughout the supply chain and administration process. The new inventive concept solves this problem by integrating distinct technologies to create a more powerful system.

The AI-Integrated Phenobarbital Sodium Stabilization System consists of a lyophilized pharmaceutical composition with an ethanol content in the range from 12000 ppm to 50000 ppm, an AI-powered monitoring module for tracking ethanol content and total impurities in real-time, IoT-enabled sensors for detecting and adjusting the vehicle/diluent composition for injection, a blockchain-based platform for tracking and verifying the authenticity and quality of the composition throughout the supply chain, and a novel material composition incorporating graphene oxide and silver nanoparticles to enhance stability and reduce total impurities. The system also includes a smart injection device integrated with a machine learning algorithm, capable of automatically adjusting the dose and composition of phenobarbital sodium for injection based on patient-specific data and real-time monitoring.

The new claims introduce the integration of AI, IoT, blockchain, and advanced materials, which is not obvious from the original patent. The inventive step lies in the synergistic combination of these technologies to create a more powerful system for stabilizing phenobarbital sodium for injection.

Alternative embodiments could include the use of different AI algorithms, IoT sensor configurations, or blockchain platforms. Variations could also involve the integration of additional technologies, such as robotics or virtual reality, to further enhance the system's capabilities.

The AI-Integrated Phenobarbital Sodium Stabilization System has significant commercial potential in the pharmaceutical industry, particularly in the areas of neonatal seizure treatment and critical care. The system's real-time monitoring and optimization capabilities could also be applied to other pharmaceutical compositions, expanding its market potential.